IRIS
LEONARDI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.947
AS - Asia 3.957
EU - Europa 3.147
SA - Sud America 705
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 232
OC - Oceania 7
Totale 16.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.649
SG - Singapore 1.094
CN - Cina 1.032
IE - Irlanda 794
HK - Hong Kong 649
BR - Brasile 522
IT - Italia 502
RU - Federazione Russa 466
VN - Vietnam 417
DE - Germania 386
FR - Francia 214
FI - Finlandia 195
BD - Bangladesh 159
GB - Regno Unito 158
IN - India 149
ZA - Sudafrica 143
CA - Canada 141
NL - Olanda 88
AT - Austria 70
MX - Messico 59
AR - Argentina 57
JP - Giappone 56
IQ - Iraq 55
TR - Turchia 45
PL - Polonia 43
SE - Svezia 40
ID - Indonesia 39
UA - Ucraina 36
ES - Italia 34
PH - Filippine 34
CO - Colombia 31
PK - Pakistan 29
CR - Costa Rica 25
SA - Arabia Saudita 24
VE - Venezuela 24
EC - Ecuador 23
AE - Emirati Arabi Uniti 22
MA - Marocco 21
UZ - Uzbekistan 21
MY - Malesia 19
BE - Belgio 18
JO - Giordania 16
CL - Cile 14
IL - Israele 14
JM - Giamaica 13
PE - Perù 13
CZ - Repubblica Ceca 11
LT - Lituania 11
TH - Thailandia 11
GT - Guatemala 10
KZ - Kazakistan 10
NI - Nicaragua 10
NP - Nepal 10
RO - Romania 10
TT - Trinidad e Tobago 10
ET - Etiopia 9
KE - Kenya 9
MK - Macedonia 9
TN - Tunisia 9
PA - Panama 8
UY - Uruguay 8
AL - Albania 7
CH - Svizzera 7
DZ - Algeria 7
PT - Portogallo 7
SV - El Salvador 7
AZ - Azerbaigian 6
EE - Estonia 6
KG - Kirghizistan 6
PR - Porto Rico 6
PY - Paraguay 6
RS - Serbia 6
SN - Senegal 6
AU - Australia 5
EG - Egitto 5
LB - Libano 5
MU - Mauritius 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
GE - Georgia 4
PS - Palestinian Territory 4
AO - Angola 3
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
KW - Kuwait 3
UG - Uganda 3
BB - Barbados 2
BH - Bahrain 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
GA - Gabon 2
GY - Guiana 2
Totale 15.962
Salva come PNG Salva come JPEG
Città #
San Jose 1.091
Dublin 790
Ashburn 754
Hong Kong 637
Chandler 552
Singapore 515
Dallas 498
Council Bluffs 459
Beijing 282
New York 218
Los Angeles 202
Lauterbourg 173
Boardman 166
Ho Chi Minh City 151
Princeton 146
Munich 140
Lawrence 138
Medford 137
Helsinki 131
Johannesburg 130
Hanoi 113
Wilmington 113
Santa Clara 89
Redondo Beach 74
Moscow 72
Nuremberg 69
Milan 68
Buffalo 62
Pavia 59
Shanghai 58
Orem 53
Chicago 50
Tokyo 48
Turku 48
Jacksonville 45
São Paulo 45
Montreal 44
Atlanta 43
Washington 43
Warsaw 41
Nanjing 39
Brooklyn 38
Falkenstein 35
Columbus 34
Vienna 33
Rio de Janeiro 32
Chennai 31
Phoenix 30
Toronto 29
London 28
North Bergen 28
Norwalk 28
San Francisco 28
Rome 27
Changsha 25
Seattle 25
Haiphong 24
The Dalles 24
Amsterdam 23
Dulles 23
Hangzhou 22
Denver 21
Frankfurt am Main 21
Baghdad 20
Da Nang 19
Ankara 18
Fairfield 18
Mexico City 18
Tashkent 18
Woodbridge 18
New Delhi 17
San José 17
Brussels 16
Hebei 16
Amman 15
Belo Horizonte 15
Houston 15
Poplar 15
Stockholm 15
Tomsk 15
Guangzhou 14
Naples 14
Redwood City 14
Ann Arbor 13
Boston 13
Quito 13
Dhaka 12
Manchester 12
Nanchang 12
Bologna 11
Charlotte 11
Curitiba 11
Florence 11
Karachi 11
Mumbai 11
Philadelphia 11
Riyadh 11
Caracas 10
Hyderabad 10
Managua 10
Totale 9.715
Salva come PNG Salva come JPEG
Nome #
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 470
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC) 360
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment 228
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis 226
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 169
Sotagliflozin in patients with diabetes and recent worsening heart failure 155
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 154
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 154
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 152
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes 151
Alirocumab and cardiovascular outcomes after acute coronary syndrome 151
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 140
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention 138
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 136
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 133
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 132
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 130
Rivaroxaban with or without aspirin in stable cardiovascular disease 130
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 130
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 129
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 128
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group 127
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 126
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 123
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 121
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 120
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 119
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 119
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention 118
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 118
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 118
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease). 117
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 115
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 115
Apixaban versus warfarin in patients with atrial fibrillation 114
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 114
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 112
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 109
Utilità della risonanza magnetica cardiaca nella valutazione del profilo emodinamico di pazienti con ipertensione polmonare post-embolica: uno studio di confronto con il cateterismo cardiaco destro. 108
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 108
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial 107
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial 106
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 105
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 104
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study 104
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 100
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 100
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 99
Role of cardiac magnetic resonance in the avaluation of the hemodynamic profile of patients with severe chronic thromboembolic pulmonary hypertension: a comparison with right heart catheterization 98
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 98
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 98
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 97
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 96
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 95
Usefulness of cardiac megnetic resonance in assessing reverse right ventricular remodeling in patients with chronic thromboembolic pulmonary hypertension after pulmonary endarteriectomy 94
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes 94
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 93
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial 93
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease 93
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 93
Incidence of ventricular arrhythmias and 1-year predictors of mortality in patients treated with implantable cardioverter-defibrillator undergoing generator replacement 93
The prognostic value of serial troponin measurements in patients admitted for COVID-19 92
Association of Troponin Levels with Mortality in Italian Patients Hospitalized with Coronavirus Disease 2019: Results of a Multicenter Study 91
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 91
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial 91
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 90
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 90
Acute Cardiovascular Care 2019 89
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? 89
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 89
Clinical governance of patients with acute coronary syndromes 88
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY 88
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y 12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: The INNOVATE-PCI trial 87
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study 87
Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes 87
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 87
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY 87
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 87
Parenteral antithrombotic therapy during primary percutaneous coronary intervention 86
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 85
A novel approach to systematically implement the universal definition of myocardial infarction: Insights from the CHAMPION PLATFORM trial 84
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome 84
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 83
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasivemanagement: Secondary analysis of a randomized clinical trial 81
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study 80
Composition, structure, and function of heart teams: A joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization 79
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score 79
Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX) 78
Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysis 76
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 75
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data 75
Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era 75
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS 75
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function 75
Use of biomarkers to predict specific causes of death in patients with Atrial fibrillation: Insights from the Aristotle Trial 75
Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study 74
[Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives] 73
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 72
Antithrombotic Therapy in Patients With Acute Coronary Syndrome Complicated by Cardiogenic Shock or Out-Of-Hospital Cardiac Arrest: A Joint Position Paper From the European Society of Cardiology (ESC) Working Group on Thrombosis, in Association With the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 72
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score 71
Totale 11.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.057
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022530 0 0 0 0 10 5 12 35 27 9 88 344
2022/20231.813 233 140 18 91 121 145 3 93 894 15 39 21
2023/2024823 60 170 39 39 74 239 9 64 2 45 31 51
2024/20252.824 80 165 29 55 74 218 225 158 732 143 304 641
2025/20267.148 614 433 753 657 867 230 1.426 382 593 562 373 258
2026/20272.423 396 690 440 860 37 0 0 0 0 0 0 0
Totale 16.241